MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹2,120 Cr | ₹1,863 Cr | ₹2,623 Cr | ₹1,353 Cr | ₹1,251 Cr |
What is the latest Total Current Liabilities ratio of MANKIND PHARMA ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹2,120 Cr |
Mar2023 | ₹1,863 Cr |
Mar2022 | ₹2,623 Cr |
Mar2021 | ₹1,353 Cr |
Mar2020 | ₹1,251 Cr |
How is Total Current Liabilities of MANKIND PHARMA Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹2,120 Cr | 13.77 | |
Mar2023 | ₹1,863 Cr | -28.98 | |
Mar2022 | ₹2,623 Cr | 93.84 | |
Mar2021 | ₹1,353 Cr | 8.21 | |
Mar2020 | ₹1,251 Cr | - |
Compare Total Current Liabilities of peers of MANKIND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANKIND PHARMA | ₹101,363.4 Cr | 2.4% | 7.1% | 3.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹407,155.0 Cr | -3.9% | 3% | 7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹147,295.0 Cr | -5% | -1.1% | 71.6% | Stock Analytics | |
CIPLA | ₹116,664.0 Cr | -4.4% | 0.2% | -1.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹107,678.0 Cr | -1.6% | 6.5% | 26.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,162.6 Cr | -2.4% | 2.4% | -5.4% | Stock Analytics |
MANKIND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANKIND PHARMA | 2.4% |
7.1% |
3.9% |
SENSEX | -2.5% |
1.9% |
4.9% |
You may also like the below Video Courses